THE EFFECT OF MULTIPLE INTRAMUSCULAR PLACEBO INJECTIONS ON INJECTION-SITE TOLERANCE AND SERUM EREATINE PHOSPHOKINASE ACTIVITY.VUKOVICH RA.1975; CURR. THERAPEUT. RES.; U.S.A.; DA. 1975; VOL. 18; NO 5; PP. 706-710; BIBL. 5 REF.Article

ENDOCRINE AND CARDIOVASCULAR CONSEQUENCES OF ANGIOTENSIN CONVERTING ENZYME INHIBITION.VUKOVICH RA; WILLARD DA; BRANNICK LJ et al.1977; J. INTERNATION. MED. RES.; G.B.; DA. 1977; VOL. 5; NO 1; PP. 1-9; BIBL. 7 REF.Article

EFFECT OF 2% PROCAINE HYDROCHLORIDE SOLUTION ON THE BIOAVAILABILITY OF CEPHRADINE AFTER INTRAMUSCULAR INJECTION.VUKOVICH RA; SUGERMAN A; FIELDS LA et al.1975; CURR. THERAPEUT. RES.; U.S.A.; DA. 1975; VOL. 18; NO 5; PP. 711-719; BIBL. 10 REF.Article

EFFECTS OF NADOLOL BETA -BLOCKADE ON BLOOD PRESSURE IN HYPERTENSIONDUCHIN KL; VUKOVICH RA; DENNICK LG et al.1980; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1980; VOL. 27; NO 1; PP. 57-63; BIBL. 16 REF.Article

METABOLIC STUDIES IN PATIENTS WITH NADOLOL: ORAL AND INTRAVENOUS ADMINISTRATION.DREYFUSS J; BRANNICK LJ; VUKOVICH RA et al.1977; J. CLIN. PHARMACOL.; U.S.A.; DA. 1977; VOL. 17; NO 5-6; PP. 300-307; BIBL. 9 REF.Article

REFRACTORY ARRHYTHMIA IN THE PRESENCE OF CONGESTIVE FAILURE: SUCCESSFUL BETA SYMPATHOLYTIC TREATMENTVUKOVICH RA; SANCHEZ ZAMBRANO S; SASAHARA AA et al.1979; AMER. HEART J.; USA; DA. 1979; VOL. 98; NO 3; PP. 399-400; BIBL. 10 REF.Article

SEX DIFFERENCES IN THE INTRAMUSCULAR ABSORPTION AND BIOAVAILABILITY OF CEPHRADINE.VUKOVICH RA; BRANNICK LJ; SUGERMAN AA et al.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 2; PP. 215-220; BIBL. 6 REF.Article

ORAL ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN LONG-TERM TREATMENT OF HYPERTENSIVE PATIENTSBRUNNER HR; GAVRAS H; WAEBER B et al.1979; ANN. INTERN. MED.; USA; DA. 1979; VOL. 90; NO 1; PP. 19-23; BIBL. 25 REF.Article

CEPHRADINE AND EPICILLIN IN BODY FLUIDS OF LACTATING AND PREGNANT WOMENMISCHLER TW; CORSON SL; LARRANAGA A et al.1978; J. REPROD. MED.; USA; DA. 1978; VOL. 21; NO 3; PP. 130-136; BIBL. 15 REF.Article

PHARMACOKINETICS AND BIOAVAILABILITY OF INDAPAMIDE. A NEW ANTIHYPERTENSIVE DRUGGREBOW PE; TREITMAN JA; BARRY EP et al.1982; EUR. J. CLIN. PHARMACOL.; ISSN 0031-6970; DEU; DA. 1982; VOL. 22; NO 4; PP. 295-299; BIBL. 10 REF.Article

RHC 3659; NEW ORALLY ACTIVE ANGIOTENSIN CONVERTING ENZYME INHIBITOR IN NORMAL VOLUNTEERSBURNIER M; TURINI GA; BRUNNER HR et al.1981; BR. J. CLIN. PHARMACOL.; ISSN 0306-5251; GBR; DA. 1981; VOL. 12; NO 6; PP. 893-899; BIBL. 14 REF.Article

DISPOSITION OF CAPTOPRIL IN NORMAL SUBJECTSKRIPALANI KJ; MCKINSTRY DN; SINGHVI SM et al.1980; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1980; VOL. 27; NO 5; PP. 636-641; BIBL. 10 REF.Article

ANTIHYPERTENSIVE EFFECT OF THE ORAL ANGIOTENSIN CONVERTING-ENZYME INHIBITOR SQ 14225 IN MAN.GAVRAS H; BRUNNER HR; TURINI GA et al.1978; NEW ENGL. J. MED.; U.S.A.; DA. 1978; VOL. 298; NO 18; PP. 991-995; BIBL. 24 REF.Article